Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.2 was added and revision: v3.5.0 was removed, indicating a version update.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated to v3.4.2, and administrative notices about government funding lapse and NIH operating status were removed.SummaryDifference0.4%

- Check74 days agoChange DetectedA general site notice about government funding lapse and NIH operations was added, and the page revision updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded Show glossary and new QC-related labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with Revision: v3.4.0. Removed the older capitalization variant labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the previous Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.